Navigation Links
Cumberland Pharmaceuticals Reports Second Quarter 2009 Financial Results
Date:8/27/2009

attributable to common shareholders - basic $0.10 $0.03 $0.24 $0.15 Earnings per share attributable to common shareholders - diluted $0.07 $0.02 $0.15 $0.09 CUMBERLAND PHARMACEUTICALS INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) Six Months Ended June 30, ------------------------- 2008 2009 ---- ---- Cash flows from operating activities: Net income $2,453,673 $1,493,266 Adjustments to reconcile net income to net cash flows from operating activities: Gain on early extinguishment of other long-term obligations (38,577) - Depreciation and amortization expense 392,896 398,341 Nonemployee stock granted for services received 27,500 182,091 Nonemployee stock option grant expense - 826,290 Stock-based compensation - employee stock options 121,725 313,064 Excess tax benefit derived from exercise of stock options (156,758) (2,842,825) Noncash interest expense 63,113 29,376 Net changes in assets and liabilities affecting operating activities: Accounts receivable (627,785) (125,024) Inventory
'/>"/>
SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Orion ICG, LLC Announces Acquisition of Cumberland Therapy Services, Inc.
2. Cumberland Pharmaceuticals Announces Appointments
3. Cumberland Pharmaceuticals to Announce Second Quarter 2009 Financial Results on August 27, 2009
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 31, 2015 As the scientific community ... Balance Network (GEBN) is poised to make meaningful ... health. GEBN is a network of scientists from ... Asia and Oceania who have banded together to further ... the body (energy balance) and apply this understanding to ...
(Date:3/31/2015)... Williams Comfort Air knows people ... their home comfort is at stake. In order ... fit into the customer’s schedule, a new online ... at requested times. , To take advantage ... the Indianapolis area can visit http://williamscomfortair.com/services-maintenance/schedule-online/ , ...
(Date:3/31/2015)... 2015 Tickets are now on sale ... tradition since 1973. The 2015 Spring production, Fairy Tales ... Ice. On April 24 in partnership with the Alzheimer's ... night tribute to the Pat Bowlen family, long-time partners ... the opening event proceeds will go to the Alzheimer's ...
(Date:3/31/2015)... 2015 Fitbody Personal Training LLC invites participants ... night or Saturday morning workouts away from the gym and ... from FitBody Personal Training LLC. The classes are moving outdoors. ... Grashof, offers boot camp outdoors on Thursday evenings starting April ... for this next session starts on April 11th and ends ...
(Date:3/31/2015)... TX (PRWEB) March 31, 2015 ... Practice Edition 2, bringing the industry’s most advanced ... the healthcare community. Physicians can now experience the ... a trusted source, offering value-added support services that ... (EHR) systems. , “QMedET is proud to provide ...
Breaking Medicine News(10 mins):Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 2Health News:Global Energy Balance Network Experts from Six Continents Join Forces to Reduce Obesity, Including the University of Colorado Anschutz Health and Wellness Center's James O. Hill, PhD 3Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:FitBody Personal Training LLC Announces its Personal Training Classes are Moving Outdoors 2Health News:QMedET Solutions Announces Addition of Dragon® Medical Practice Edition 2 to its Roster of Products 2
... imaging technology is expected to help physicians better classify ... cleared by the FDA that allows doctors to ... This new technique may significantly reduce the need for ... 20 percent of biopsies turn up positive for cancer. ...
... California Alliance for Inclusive Communities (CAIC) has recently joined ... They join the majority of state and national disability ... an advocacy group that works on behalf of groups ... ,Just as a new national AP/Ipsis poll was ...
... and Chembio Diagnostics, Inc. (OTC Bulletin Board: CEMI) ... agreements for the development of rapid diagnostic tests ... by IDRI. The tests will be developed by ... platform (DPP(TM)) and will incorporate IDRI's proprietary antigens. ...
... Council announces the launch of Global Health TV, a ... experts and civil society on the major health issues ... service is a collaborative project between HBL Media, a ... Global Health TV website, http: www.globalhealthtv.com, will bring viewers ...
... tend to lose muscle mass and grow frail? One important ... the elderly to respond to the muscle-building stimulus of the ... its link to diabetes a condition in which either ... hormone's activity (as in type 2 diabetes) causes blood sugar ...
... risk factors beyond those expected from weight loss in ... due to the drug itself, reports an article in ... ,Advertisements for rimonabant (sold under the ... 50% of the effects on cardiometabolic risk factors ...
Cached Medicine News:Health News:IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy 2Health News:IDRI and Chembio to Develop Tests for Leishmaniasis and Leprosy 3Health News:Aerobic Exercise Helps Maintain Muscle in Elderly: Research 2Health News:Anti-obesity Drugs Claimed Additional Benefits on cardiometabolic Risk Factors Questioned 2
(Date:3/31/2015)... NEW YORK , March 31, 2015 ... ) announced today that it intends to expand its ... fully human monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is ... approximately 60,000 patients in the US and ... expects to start enrolling patients in a Phase II ...
(Date:3/31/2015)... , March 31, 2015   Unique Pharmaceuticals , ... is complete and the company has initiated sterile compounding ... "Our goal as a company is to meet and ... Leeah . "Meeting the new regulations is validation of ... embracing the future of our industry, investing in its ...
(Date:3/31/2015)... , Mar. 27, 2015 Research and Markets ... addition of the "North American Laboratory Information ... System), by Type (Clinical Pathology Laboratory Information System, ... 2019" report to their offering. ... estimated to grow at a CAGR of 7.8% ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... cherry tree saplings were planted in Central Park of ... County Park System, located in Parsippany Troy-Hills.  The planting ... 100th anniversary of the historic gift of Japanese flowering ...  More than 75 Daiichi Sankyo employee volunteers partnered with ...
... Romark Laboratories announced that results of a large ... drug, NT-300 (nitazoxanide), will be presented as an oral ... Infectious Diseases Society of America (IDSA) being held in ... The clinical trial enrolled 624 patients at ...
Cached Medicine Technology:Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 2Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 3Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey 4Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 2Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 3Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 4Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 5Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 6Romark Announces Clinical Trial Results for New Influenza Drug Presented at IDSA Meeting 2011 7
MagaCell-Streptavidin is a streptavidin coupled to magnetizable cellulose/iron oxide particles...
For general purposes...
Streptavidin A-Beads are polydisperse 1.8 m paramagnetic particles covalently coupled with streptavidin. The paramagnetic particles remain in solution over extended periods of time. Mixing is require...
... method for isolating antibodies, antigens, lectins, ... affinity binding, while retaining biological activity. ... particles to separate biotinylated molecules from ... Beads from the suspension, an external ...
Medicine Products: